MedPath

A method of pain reduction during prostate biopsy

Phase 2
Conditions
Dysplasia of prostate.
Dysplasia of Prostate, Low grade dysplasia
Registration Number
IRCT201612013773N17
Lead Sponsor
Vice chancellor for research of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
96
Inclusion Criteria

Patients candidate for prostate biopsy; Minimum weight 40 kg
Exclusion criteria: uncontrolled blood pressure; sensitivity to local anesthetics; advanced heart, renal or hepatic disease; opioid addiction.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before and During Biopsy. Method of measurement: VAS Score.;Blood Pressure. Timepoint: Before and During Biopsy. Method of measurement: Monitoring.;Heart Rate. Timepoint: Before and During Biopsy. Method of measurement: Pulse Oximetry.
Secondary Outcome Measures
NameTimeMethod
evel of consciousness. Timepoint: Before and during biopsy. Method of measurement: Miller Score.
© Copyright 2025. All Rights Reserved by MedPath